Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematologic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06506461
What this trial is testing

Gene Editing For Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 25
Not applicableStudy completedNCT04045561
What this trial is testing

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nīmes 10
Testing effectiveness (Phase 2)Ended earlyNCT00699842
What this trial is testing

A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients

Who this might be right for
Myelodysplastic SyndromeMDSLow to Intermediate-1 MDS+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 8
Testing effectiveness (Phase 2)Study completedNCT00322842
What this trial is testing

Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinMultiple Myeloma
Genzyme, a Sanofi Company 35
Post-approval studies (Phase 4)Study completedNCT00346242
What this trial is testing

Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal Events

Who this might be right for
Thalassemia
Novartis Pharmaceuticals 60
Not applicableStudy completedNCT01533168
What this trial is testing

Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 12
Early research (Phase 1)UnknownNCT03093168
What this trial is testing

BCMA Chimeric Antigen Receptor Expressing T Cells in Multiple Myeloma

Who this might be right for
Multiple Myeloma
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 10
Not applicableStudy completedNCT01110850
What this trial is testing

Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water

Who this might be right for
Chronic Lymphocytic Leukemia
Northwell Health 24
Large-scale testing (Phase 3)Looking for participantsNCT06182774
What this trial is testing

Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Canadian Cancer Trials Group 570
Not applicableStudy completedNCT03500497
What this trial is testing

The Change in RetHe - Levels Perioperatively in a Cohort of Colorectal Surgery Patient

Who this might be right for
AnemiaColorectal SurgeryPerioperative
Maastricht University Medical Center 164
Testing effectiveness (Phase 2)UnknownNCT00927797
What this trial is testing

Interventional Study on Pentostatin, Cyclophosphamide and Rituximab in Indolent B-Cell Non-Hodgkin-Lymphoma (B-NHL)

Who this might be right for
Immunocytoma/Morbus WaldenströmB-Cell Non-Hodgkin's LymphomaB-Cell Chronic Lymphocytic Leukemia
Heidelberg University 185
Large-scale testing (Phase 3)Ended earlyNCT03504410
What this trial is testing

Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
Cornerstone Pharmaceuticals 200
Not applicableStudy completedNCT00296023
What this trial is testing

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
University of California, San Francisco 25
Post-approval studies (Phase 4)Study completedNCT00437723
What this trial is testing

NeoRecormon in Patients With Chronic Kidney Disease.

Who this might be right for
Anemia
Hoffmann-La Roche 90
Testing effectiveness (Phase 2)Looking for participantsNCT05327023
What this trial is testing

Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Who this might be right for
Hematologic Neoplasms
National Cancer Institute (NCI) 430
Not applicableStudy completedNCT03328780
What this trial is testing

Anemia in Orthopedic Surgery - Determination of Hb

Who this might be right for
Anemia
Theusinger Oliver M. 300
Testing effectiveness (Phase 2)Looking for participantsNCT05776979
What this trial is testing

Post-Transplant Maintenance Therapy With Isatuximab Plus Lenalidomide for High-Risk Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
M.D. Anderson Cancer Center 61
Not applicableLooking for participantsNCT06281496
What this trial is testing

AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematological Diseases
Rigshospitalet, Denmark 100
Very early researchStudy completedNCT02802696
What this trial is testing

Transfusion-Associated Circulatory Overload Best Eliminated With Lasix

Who this might be right for
Transfusion-associated Circulatory Overload
Sunnybrook Health Sciences Centre 80
Early research (Phase 1)Ended earlyNCT02255162
What this trial is testing

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Who this might be right for
Acute Myeloid Leukemia (AML)Acute Myelocytic LeukemiaAcute Myelogenous Leukemia+2 more
Massachusetts General Hospital 8
Next Page